ABCL
Abcellera Biologics Inc
14.60$
-1.6%
vs. previous close
Closing price · As of: Sep 30, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Abcellera Biologics Inc (ABCL) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/13/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
| 08/11/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.